Dried Blood Spot Biomarkers May Help Identify Congenital Heart Disease In Newborns, Study Finds

Healio (7/1, Weldon) reports, “Biomarkers in dried blood spot testing may help identify congenital heart disease in newborns, according to a study in JAMA Network Open.” In the study, researchers “found that, combined, NT-proBNP and IL-1 RL1 had a positive predictive value of identifying high-risk congenital heart disease of 95.7%, a negative predictive value of 88.1%, a sensitivity of 93.6%, and a specificity of 91.8%, with an overall accuracy of 93%.”